Lincomix InjectableThis page contains information on Lincomix Injectable for veterinary use.
The information provided typically includes the following:
- Lincomix Injectable Indications
- Warnings and cautions for Lincomix Injectable
- Direction and dosage information for Lincomix Injectable
Lincomix InjectableThis treatment applies to the following species:
NDC 0009-0617-13, NDC 0009-3256-01
Brand of Lincomycin Hydrochloride, USP
For Intramuscular Use in Swine Only
LINCOMIX Injectable contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis, which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.
Lincomix Injectable Indications For Swine
LINCOMIX Injectable is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as the staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.
It is also indicated for the treatment of mycoplasma pneumonia.
As with all drugs, the use of LINCOMIX Injectable is contraindicated in animals previously found to be hypersensitive to the drug.
Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment. Not for human use.
Lincomix Injectable Caution
If no improvement is noted within 48 hours, consult a veterinarian.
The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur.
Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.
Lincomix Injectable Dosage And Administration
For arthritis or mycoplasma pneumonia-5 mg per pound of body weight intramuscularly once daily for three to seven days as needed. When using LINCOMIX Injectable containing 100 mg/mL, 1 mL/20 lb body weight will provide 5 mg/lb. When using LINCOMIX Injectable containing 300 mg/mL, 1 mL/60 lb body weight will provide 5 mg/lb.
For optimal results, initiate treatment as soon as possible.
As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.
LINCOMIX Injectable is available in three concentrations: 300 mg/mL and 100 mg/mL.
300 mg/mL: For use in swine weighing 300 pounds or more. Each mL contains lincomycin hydrochloride equivalent to lincomycin, 300 mg; also Benzyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.
100 mg/mL: Each mL contains lincomycin hydrochloride equivalent to lincomycin, 100 mg; also Benzyl Alcohol, 9.45 mg added as preservative. Supplied in 100 mL vials.
Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].
NADA #34-025, Approved by FDA
Pharmacia & Upjohn Company, Kalamazoo, Michigan 49001, USA
Revised August 1999
810 601 211
NAC No.: 10490282
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Customer Service:||800-733-5500 and 800-793-0596|
|Veterinary Medical Investigations & Product Support:||800-366-5288|
|Technical Services (USA):||800-366-5288|
|Every effort has been made to ensure the accuracy of the Lincomix Injectable information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2014-07-28